Stevanato Group S.p.A. (STVN) Announces $300M Share Offering

Go back to Stevanato Group S.p.A. (STVN) Announces $300M Share Offering

Stevanato Group Announces Public Offering of Ordinary Shares

March 20, 2024 5:12 PM EDT

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN) (Stevanato Group, or the Company), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the launch of an underwritten public offering of an aggregate of $300,000,000 of its ordinary shares.

Stevanato Group is offering $150,000,000 of its ordinary shares (the Company Offering), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the Selling Shareholder), which currently holds approximately 78% of Stevanato Groups outstanding ordinary shares, is offering $150,000,000 of... More